| Dr Benjamin Nelson, MD | |
|
620 John Paul Jones Circle, Portsmouth, VA 23708 | |
| (757) 953-7716 | |
| Not Available |
| Full Name | Dr Benjamin Nelson |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 620 John Paul Jones Circle, Portsmouth, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245496520 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 0101246168 (Virginia) | Primary |
| Entity Name | Childrens Specialty Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255354130 PECOS PAC ID: 5890788764 Enrollment ID: O20040406001195 |
News Archive
A research collaboration between the Wyss Institute for Biologically Inspired Engineering at Harvard University and Children's Hospital Boston has developed "smart" injectable nanotherapeutics that can be programmed to selectively deliver drugs to the cells of the pancreas. Although this nanotechnology will need significant additional testing and development before being ready for clinical use, it could potentially improve treatment for Type I diabetes by increasing therapeutic efficacy and reducing side effects.
Boston Medical Center pediatricians Laura Johnson, MD, MPH, Jenny Radesky, MD, and Barry Zuckerman, MD, the Joel and Barbara Alpert Professor of Pediatrics at Boston University School of Medicine, have published a paper in the current issue of the journal Pediatrics that addresses how understanding the origins and goals of parenting behaviors can help pediatricians strengthen relationships with families, demonstrate cultural sensitivity, and more effectively offer guidance on the challenges of childrearing.
Testing a representative sample of Orange County residents for a wide range of coronavirus antibodies, University of California, Irvine researchers found that 11.5 percent of them have antibodies for COVID-19, in contrast to previous estimates of less than 2 percent.
Baxter International Inc. today provided an update on its clinical program evaluating the use of its GAMMAGARD LIQUID 10%, for the treatment of mild to moderate Alzheimer's disease.
Ryogen LLC announced today that the company have entered into a nonexclusive license agreement with Invitrogen Corporation, whereby Invitrogen has licensed from Ryogen the patent directed to the clinically important Aminopeptidase P gene.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Benjamin Nelson, MD 620 John Paul Jones Circle, Portsmouth, VA 23708 Ph: (757) 953-7716 | Dr Benjamin Nelson, MD 620 John Paul Jones Circle, Portsmouth, VA 23708 Ph: (757) 953-7716 |
News Archive
A research collaboration between the Wyss Institute for Biologically Inspired Engineering at Harvard University and Children's Hospital Boston has developed "smart" injectable nanotherapeutics that can be programmed to selectively deliver drugs to the cells of the pancreas. Although this nanotechnology will need significant additional testing and development before being ready for clinical use, it could potentially improve treatment for Type I diabetes by increasing therapeutic efficacy and reducing side effects.
Boston Medical Center pediatricians Laura Johnson, MD, MPH, Jenny Radesky, MD, and Barry Zuckerman, MD, the Joel and Barbara Alpert Professor of Pediatrics at Boston University School of Medicine, have published a paper in the current issue of the journal Pediatrics that addresses how understanding the origins and goals of parenting behaviors can help pediatricians strengthen relationships with families, demonstrate cultural sensitivity, and more effectively offer guidance on the challenges of childrearing.
Testing a representative sample of Orange County residents for a wide range of coronavirus antibodies, University of California, Irvine researchers found that 11.5 percent of them have antibodies for COVID-19, in contrast to previous estimates of less than 2 percent.
Baxter International Inc. today provided an update on its clinical program evaluating the use of its GAMMAGARD LIQUID 10%, for the treatment of mild to moderate Alzheimer's disease.
Ryogen LLC announced today that the company have entered into a nonexclusive license agreement with Invitrogen Corporation, whereby Invitrogen has licensed from Ryogen the patent directed to the clinically important Aminopeptidase P gene.
› Verified 5 days ago
Justin Hollon, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 620 John Paul Jones Circle, Naval Medical Center Portsmouth, Portsmouth, VA 23708 Phone: 757-953-4529 Fax: 757-953-3293 | |
Dr. Mary Elizabeth Watson, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 620 John Paul Jones Cir, Naval Medical Center Portsmouth, Dept. Of Pediatrics, Portsmouth, VA 23708 Phone: 757-953-2960 | |
Dr. Clinton Forrest Faison Iii, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 620 John Paul Jones Circle, Naval Medical Center Portsmouth, Portsmouth, VA 23708 Phone: 757-953-7424 Fax: 757-953-5104 | |
Dr. Rebecca D. Christi, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-5652 | |
Dr. Shawn Jamison Miller, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 620 John Paul Jones Cir, Naval Medical Center Portsmouth, Portsmouth, VA 23708 Phone: 757-953-2958 | |
Dr. Arek Hidirsah, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 620 John Paul Jones Cir Dept Aya, Portsmouth, VA 23708 Phone: 757-953-0167 Fax: 757-953-0058 | |
Dr. John Kenyon Watson, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-2983 Fax: 757-953-0858 |